Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04159974
Title RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus (RICE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cologne
Indications

gastroesophageal junction adenocarcinoma

gastric cardia adenocarcinoma

esophagus adenocarcinoma

Therapies

Durvalumab

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.